EDITORIAL Dr. Matías Sztejfman ARTICULO DE REVISION Dr. Fernando Cura Implante Valvular Aórtico en pacientes de alto riesgo quirúrgico, evidencia y hacia donde nos dirigimos REVISION BIBLIOGRAFICA Dr. Yigal Piña Reyna Estudio CoreValve US Pivotal en Pacientes de alto riesgo quirúrgico CASO CLINICO Dres. Gabriel Maluenda, Mario Araya y Michael Howard TAVI con Sapien XT™...
1. ESTUDIOS DE TECNOLOGIAS EN INTERVENCIONES CORONARIAS • RIBS IV – Presentador: Fernando Alfonso • ABSORB II – Presentador: Patrick Serruys 2. ESTUDIOS DE FARMACOLOGIA EN INTERVENCIONES CORONARIAS • ISAR-TRIPLE – Presentador: Nikolaus Sarafoff • SECURITY – Presentador: Antonio Colombo • BRIGHT – Presentador: Yalin Hang 3. ESTUDIOS EN IMÁGENES CORONARIAS • IVUS-CTO – Presentador:...
SINDROME CORONARIO AGUDO • Infarto Agudo de Miocardio: Nuevo Paradigma en el tratamiento de STEMI – Dr. Luis Guzmán • Nuevas estrategias de reperfusión miocárdica en el Infarto Agudo de Miocardio con Elevación del Segmento ST – Dr. José Armando Mangione ANGIOPLASTIA TRANSLUMINAL CORONARIA EN SITUACIONES ESPECIALES • ¿Cuál es la mejor estrategia en las bifurcaciones? – Dr....
Original title: Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Disease. Reference: Darren Mylotte, et al. J Am Coll Cardiol 2014;64:2330-9 The bicuspid aortic valve (BAV) is present between 0.5% and 2% of the general population and up to 20% of patients older than 80 years who require aortic valve surgery. Literature on transcatheter aortic valve...
October 30 – 31, 2014, at Intercontinental Hotel Cali, Colombia. For information and registration write to jornadas@solaci.org Como actividad previa al inicio de las Jornadas SOLACI en Colombia, los doctores José Luis Leiva Pons, Pedro Hidalgo, Marcelo Halac y Antonio Dager practican una implantación de válvula aórtica (TAVI) en el instituto Angiografia de Occidente...
Original title: Early Regression of Severe Left Ventricular Hypertrophy After Transcatheter Aortic Valve Replacement Is Associated with Decreased Hospitalization. Reference: Brian Lindman, et al. JACC Cardiovasc Interv 2014;7:662-73. Left ventricular hypertrophy, defined by the increase of left ventricular mass, has long been associated to increased morbi-mortality in the context of different heart conditions. LV hypertrophy regression might...
Original title: Relation of Pre-procedural Assessment of Myocardial Contractility Reserve on Outcomes of Aortic Stenosis Patients with Impaired Left Ventricular Function Undergoing Transcatheter Aortic Valve Implantation Reference: Israel M. Barbash et al. Am J Cardiol. 2014, Epub ahead of print. Transcatheter aortic valve replacement (TAVI) is associated with a better left ventricular function (LV) in patients with...
Original title: Reduction of pacemaker implantation rates alter CoreValve implantation by moderate predilatation Reference: Philipp Lange, et al. EuroIntervention 2014;9:1151-1159 Aortic valve implantation has been proven a valid strategy to treat high risk patients. The CoreValve self-expanding transcatheter aortic valve is associated with a relatively high rate of permanent pacemaker implantation and, until now, no efforts have been...
Original title: Automated 3-Dimensional Aortic Annular Assessment by Multidetector Computed Tomography in Transcatheter Aortic Valve Implantation. Reference: Yusuke Watanabe et al. J Am Coll Cardiol Intv 2013;6:955–64. Percutaneous aortic valve implantation ( TAVI ) has emerged as an alternative for patients with severe aortic stenosis and high surgical risk. While this technique was improved over the time, residual paravalvular regurgitation...
Original title: Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. Reference: Francesco Saia et al. EuroIntervention 2013;8:1388-1397 Until a few years ago, aortic valvuloplasty had been abandoned by many centers due to its limited results and frequent complications. The current guidelines recommend aortic valvuloplasty to treat patients with symptomatic...